TrialCancer immunology, immunotherapy : CII2015

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.

Pia Vihinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.